Cubicin — Class I drug recall D-764-2014
Terminated recall by Cubist Pharmaceuticals, Inc., reported 2014-01-29, distributed nationwide. Presence of Particulate Matter; Glass particulates observed in vials
| Recall number | D-764-2014 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Cubist Pharmaceuticals, Inc., Lexington, MA, United States |
| Recall initiated | 2013-08-29 |
| Classified | 2014-01-17 |
| Reported by FDA | 2014-01-29 |
| Terminated | 2015-02-10 |
| Distributed | Nationwide (US) |
| Quantity | 179,870 vials |
| Reason classes | foreign material, specification failure |
| Lot numbers | 090203F, 201653F, 201703F, 950453F |
| Expiration dates | 2013-12-06, 2014-09-07, 2015-08-31, 2015-09-01 |
Product
Cubicin (daptomycin for injection), 500 mg lyophilized powder, 10 mL single-use vials, Rx only, Manufactured for Cubist Pharmaceuticals, Inc., Lexington, MA
Reason for recall
Presence of Particulate Matter; Glass particulates observed in vials
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-764-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.